Antares Financial Statements From 2010 to 2024
| ATRSDelisted Stock | USD 5.59 0.00 0.00% |
Check Antares Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Antares main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Antares financial statements analysis is a perfect complement when working with Antares Pharma Valuation or Volatility modules.
Antares |
Antares Pharma Company Current Valuation Analysis
Antares Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Antares Pharma Current Valuation | 904.7 M |
Most of Antares Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Antares Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Antares Pharma has a Current Valuation of 904.7 M. This is 93.7% lower than that of the Healthcare sector and 90.11% lower than that of the Medical Instruments & Supplies industry. The current valuation for all United States stocks is 94.56% higher than that of the company.
Antares Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Antares Pharma's current stock value. Our valuation model uses many indicators to compare Antares Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Antares Pharma competition to find correlations between indicators driving Antares Pharma's intrinsic value. More Info.Antares Pharma is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies reporting about 0.23 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Antares Pharma is roughly 4.32 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Antares Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Antares Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Antares Pharma's earnings, one of the primary drivers of an investment's value.About Antares Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Antares Pharma income statement, its balance sheet, and the statement of cash flows. Antares Pharma investors use historical funamental indicators, such as Antares Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Antares Pharma investors may use each financial statement separately, they are all related. The changes in Antares Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Antares Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Antares Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Antares Pharma. Please read more on our technical analysis and fundamental analysis pages.
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. Antares Pharma, Inc. was incorporated in 1979 and is headquartered in Ewing, New Jersey. Antares Pharma operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 201 people.
Pair Trading with Antares Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Antares Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antares Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Antares Stock
| 0.45 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.42 | HOCPY | Hoya Corp | PairCorr |
| 0.42 | MUFG | Mitsubishi UFJ Financial Financial Report 20th of May 2024 | PairCorr |
The ability to find closely correlated positions to Antares Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Antares Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Antares Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Antares Pharma to buy it.
The correlation of Antares Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Antares Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Antares Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Antares Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Antares Stock
If you are still planning to invest in Antares Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Antares Pharma's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |